| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $78.1M | +296.3% |
| R&D Expense | $177.7M | +1.5% |
| SG&A Expense | $69.7M | -1.5% |
| Operating Income | -$169.2M | +25.1% |
| Income Tax | $0 | — |
| Net Income | -$153.2M | +30.5% |
| EPS (Basic) | -$2.02 | +37.1% |
| EPS (Diluted) | -$2.02 | +37.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $123.7M | -12.6% |
| Short-term Investments | $199.5M | -1.6% |
| Accounts Receivable | $10.2M | +98.0% |
| Current Assets | $340.8M | -4.5% |
| Total Assets | $499.2M | -2.9% |
| Current Liabilities | $63.2M | +5.2% |
| Total Liabilities | $150.1M | -2.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$132.2M | +25.5% |
| Capital Expenditures | $4.7M | +14.6% |
| Investing Cash Flow | -$3.7M | -103.3% |
| Financing Cash Flow | $118.0M | +9093.1% |
| Free Cash Flow | -$136.9M | +24.6% |
| Stockholders' Equity |
| $349.1M |
| -3.2% |